Russell Investments Group
PJP icon

Russell Investments Group’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Russell Investments Group’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-25
Closed -$2.59K – 4487
2026
Q1 		$2.59K Buy
+25
New +$2.64K ﹤0.01% 3977

Other funds holding PJP

PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
JGCM
Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

Russell Investments Group's PJP Position: Q2 2026 in Review

Russell Investments Group sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2026, closing a stake of 25 shares — an estimated $2.59K sold.

Russell Investments Group first reported a position in PJP in Q1 2026 and held it in 1 quarter. The position peaked at $2.59K in Q1 2026. 116 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

  • Russell Investments Group reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2026 after selling out during the quarter.
  • Russell Investments Group sold 25 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $2.59K.
  • Russell Investments Group first reported a position in Invesco Pharmaceuticals ETF in Q1 2026 and held it in 1 quarter.
  • Russell Investments Group's Invesco Pharmaceuticals ETF position peaked at $2.59K in Q1 2026.
  • 116 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.